183 related articles for article (PubMed ID: 32438892)
1. The effect of using fecal testing after a negative sigmoidoscopy on the risk of death from colorectal cancer.
Doubeni CA; Corley DA; Jensen CD; Schottinger JE; Lee JK; Ghai NR; Levin TR; Zhao WK; Saia CA; Wainwright JV; Mehta SJ; Selby K; Doria-Rose VP; Zauber AG; Fletcher RH; Weiss NS
J Med Screen; 2021 Jun; 28(2):140-147. PubMed ID: 32438892
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of colonoscopy in screening for colorectal cancer.
Sonnenberg A; Delcò F; Inadomi JM
Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584
[TBL] [Abstract][Full Text] [Related]
3. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy.
Winawer SJ; Flehinger BJ; Schottenfeld D; Miller DG
J Natl Cancer Inst; 1993 Aug; 85(16):1311-8. PubMed ID: 8340943
[TBL] [Abstract][Full Text] [Related]
4. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
Lieberman DA; Weiss DG;
N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of colorectal cancer screening: comparison of community-based flexible sigmoidoscopy with fecal occult blood testing and colonoscopy.
O'Leary BA; Olynyk JK; Neville AM; Platell CF
J Gastroenterol Hepatol; 2004 Jan; 19(1):38-47. PubMed ID: 14675241
[TBL] [Abstract][Full Text] [Related]
6. Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study.
Doubeni CA; Weinmann S; Adams K; Kamineni A; Buist DS; Ash AS; Rutter CM; Doria-Rose VP; Corley DA; Greenlee RT; Chubak J; Williams A; Kroll-Desrosiers AR; Johnson E; Webster J; Richert-Boe K; Levin TR; Fletcher RH; Weiss NS
Ann Intern Med; 2013 Mar; 158(5 Pt 1):312-20. PubMed ID: 23460054
[TBL] [Abstract][Full Text] [Related]
7. Fecal occult blood and flexible sigmoidoscopy screening for colorectal cancer: modeling the impact on colonoscopy requirements and cancer detection rates.
Olynyk JK; Platell CF; Collett JA
J Gastroenterol Hepatol; 2001 Apr; 16(4):389-92. PubMed ID: 11354276
[TBL] [Abstract][Full Text] [Related]
8. Which colon cancer screening test? A comparison of costs, effectiveness, and compliance.
Vijan S; Hwang EW; Hofer TP; Hayward RA
Am J Med; 2001 Dec; 111(8):593-601. PubMed ID: 11755501
[TBL] [Abstract][Full Text] [Related]
9. Colorectal cancer screening: a community case-control study of proctosigmoidoscopy, barium enema radiography, and fecal occult blood test efficacy.
Scheitel SM; Ahlquist DA; Wollan PC; Hagen PT; Silverstein MD
Mayo Clin Proc; 1999 Dec; 74(12):1207-13. PubMed ID: 10593348
[TBL] [Abstract][Full Text] [Related]
10. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
11. Colorectal cancer screening: scientific review.
Walsh JM; Terdiman JP
JAMA; 2003 Mar; 289(10):1288-96. PubMed ID: 12633191
[TBL] [Abstract][Full Text] [Related]
12. From guaiac to immune fecal occult blood tests: the emergence of technology in colorectal cancer screening.
Greenwald B
Gastroenterol Nurs; 2005; 28(2):90-6. PubMed ID: 15832108
[TBL] [Abstract][Full Text] [Related]
13. Is the type of test used for mass colorectal cancer screening a determinant of compliance? A cluster-randomized controlled trial comparing fecal occult blood testing with flexible sigmoidoscopy.
Federici A; Marinacci C; Mangia M; Borgia P; Giorgi Rossi P; Guasticchi G
Cancer Detect Prev; 2006; 30(4):347-53. PubMed ID: 16965874
[TBL] [Abstract][Full Text] [Related]
14. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
[TBL] [Abstract][Full Text] [Related]
15. Screening for colorectal neoplasms. A comparison of the fecal occult blood test and endoscopic examination.
Letsou G; Ballantyne GH; Zdon MJ; Zucker KA; Modlin IM
Dis Colon Rectum; 1987 Nov; 30(11):839-43. PubMed ID: 3677957
[TBL] [Abstract][Full Text] [Related]
16. Flexible sigmoidoscopy versus fecal occult blood testing for colorectal cancer screening in asymptomatic individuals.
Stern C
Clin J Oncol Nurs; 2014 Aug; 18(4):471-2. PubMed ID: 25095304
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the occult blood test in screening for colorectal neoplasms. A prospective study using flexible endoscopy.
Reilly JM; Ballantyne GH; Fleming FX; Zucker KA; Modlin IM
Am Surg; 1990 Mar; 56(3):119-23. PubMed ID: 2316930
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis of colorectal cancer screening methods in Iran.
Allameh Z; Davari M; Emami MH
Arch Iran Med; 2011 Mar; 14(2):110-4. PubMed ID: 21361717
[TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer screening in asymptomaic adults: comparison of colonoscopy, sigmoidoscopy and fecal occult blood tests.
Cheng TI; Wong JM; Hong CF; Cheng SH; Cheng TJ; Shieh MJ; Lin YM; Tso CY; Huang AT
J Formos Med Assoc; 2002 Oct; 101(10):685-90. PubMed ID: 12517041
[TBL] [Abstract][Full Text] [Related]
20. Association of Race and Socioeconomic Status With Colorectal Cancer Screening, Colorectal Cancer Risk, and Mortality in Southern US Adults.
Warren Andersen S; Blot WJ; Lipworth L; Steinwandel M; Murff HJ; Zheng W
JAMA Netw Open; 2019 Dec; 2(12):e1917995. PubMed ID: 31860105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]